Inventor · disambiguated record
Mark A. Rubin
Also filed as: RUBIN MARK · RUBIN MARK A
23 granted patents·16 pending applications·288 citations·filing 2002–2023
95Inventor score
Top patents by PatentIndex Score
39 records- 0196US7718369B2Recurrent gene fusions in prostate cancerUNIV MICHIGAN·Filed 2006·Granted May 18, 2010·48 cites·5 claims
- 0295US7981609B2Methods for identifying and using SNP panelsBRIGHAM & WOMENS HOSPITAL·Filed 2007·Granted Jul 19, 2011·61 cites·12 claims
- 0394US7229774B2Expression profile of prostate cancerUNIV MICHIGAN·Filed 2002·Granted Jun 12, 2007·89 cites·10 claims
- 0492US9745635B2Recurrent gene fusions in prostate cancerUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 29, 2017·4 cites·18 claims
- 0590US10190173B2Recurrent gene fusions in prostate cancerUNIV MICHIGAN REGENTS·Filed 2016·Granted Jan 29, 2019·3 cites·16 claims
- 0690US8580509B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2012·Granted Nov 12, 2013·7 cites·18 claims
- 0788US8211645B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2009·Granted Jul 3, 2012·9 cites·17 claims
- 0887US7666595B2Biomarkers for predicting prostate cancer progressionBRIGHAM & WOMENS HOSPITAL·Filed 2006·Granted Feb 23, 2010·11 cites·38 claims
- 0985US7332290B2Dectection of AMACR cancer markers in urineUNIV MICHIGAN·Filed 2004·Granted Feb 19, 2008·36 cites·8 claims
- 1084US9284609B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2012·Granted Mar 15, 2016·3 cites·23 claims
- 1176US8969527B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2012·Granted Mar 3, 2015·1 cites·11 claims
- 1276US7767393B2Expression profile of prostate cancerUNIV MICHIGAN·Filed 2006·Granted Aug 3, 2010·4 cites·4 claims
- 1376US2022389523A1Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphologyVENTANA MED SYST INC·Filed 2022·Application pending·0 cites
- 1475US9866513B2Systems and methods to control the lifetime of online postsERODR INC·Filed 2014·Granted Jan 9, 2018·4 cites·16 claims
- 1575US8106037B2Identification and treatment of estrogen responsive prostate tumorsRUBIN MARK·Filed 2008·Granted Jan 31, 2012·4 cites·20 claims
- 1675US2025344736A1Fat reduction in non-animal protein compositionsFIRMENICH & CIE·Filed 2023·Application pending·0 cites
- 1767US9090899B2Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fusionRUBIN MARK A·Filed 2010·Granted Jul 28, 2015·2 cites·15 claims
- 1867US7803552B2Biomarkers for predicting prostate cancer progressionBRIGHAM & WOMENS HOSPITAL·Filed 2009·Granted Sep 28, 2010·1 cites·32 claims
- 1967US2011020517A1Taste modifying productRUBIN MARK·Filed 2009·Application pending·0 cites
- 2066US11441189B2Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphologyVENTANA MED SYST INC·Filed 2018·Granted Sep 13, 2022·0 cites·17 claims
- 2164US9951388B2Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysisDEMICHELIS FRANCESCA·Filed 2012·Granted Apr 24, 2018·1 cites·5 claims
- 2260US2024325429A1Minor spliceosome targeting compositions and their use in cancer treatmentUNIV BERN·Filed 2022·Application pending·0 cites
- 2359US2011020518A1Taste modifying productDELORT ESTELLE·Filed 2009·Application pending·0 cites
- 2456US2024287615A1Cancer methodsUNIV LONDON·Filed 2022·Application pending·0 cites
- 2552US2022167642A1Fat blends, emulsions thereof, and related usesFIRMENICH & CIE·Filed 2020·Application pending·0 cites
- 2649US2015104440A1MiRNA-31 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC AGENT IN CANCERUNIV CORNELL·Filed 2013·Application pending·0 cites
- 2749US2023397627A1Uses of fat blends and emulsions thereofFIRMENICH & CIE·Filed 2021·Application pending·0 cites
- 2847US2015056347A1Food products having an improved appeal to pet owners and at least a maintained palatability to pets, and methods of preparationSPECIALITES PET FOOD·Filed 2013·Application pending·0 cites
- 2946US2020234307A1Systems and methods for detecting periodic patterns in large datasetsFIS FINANCIAL COMPLIANCE SOLUTIONS LLC·Filed 2020·Application pending·0 cites
- 3046US2018131663A1Systems and Methods to Control the Lifetime of Online PostsERODR INC·Filed 2018·Application pending·0 cites
- 3145US9678077B2ERG/TFF3/HMWCK triple immunostain for detection of prostate cancerUNIV CORNELL·Filed 2013·Granted Jun 13, 2017·0 cites·17 claims
- 3245US2008008704A1Methods of treating colorectal cancer with anti-epidermal growth factor antibodiesRUBIN MARK·Filed 2007·Application pending·0 cites
- 3344US2014037561A1Composition and methods of enhanced skin cell turnoverKULESZA JOHN E·Filed 2011·Application pending·0 cites
- 3443US10443102B2Recurrent SPOP mutations in prostate cancerRUBIN MARK A·Filed 2012·Granted Oct 15, 2019·0 cites·21 claims
- 3543US2019114640A1Systems and methods for detecting periodic patterns in large datasetsFIS FINANCIAL COMPLIANCE SOLUTIONS LLC·Filed 2018·Application pending·0 cites
- 3639US9568483B2Molecular subtyping, prognosis and treatment of prostate cancerRUBIN MARK A·Filed 2012·Granted Feb 14, 2017·0 cites·9 claims
- 3738US9458213B2Compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcriptRUBIN MARK A·Filed 2010·Granted Oct 4, 2016·0 cites·3 claims
- 3835US10294476B2NEAT1 as a prognostic marker and therapeutic target for prostate cancerUNIV CORNELL·Filed 2015·Granted May 21, 2019·0 cites·24 claims
- 3935US2022329697A1Systems and methods for detection of toll-free routing interruptions and correction of sameINTELIQUENT INC·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →